SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

KTA CRYPTO is drawing significant attention as a Layer 1 network building high-speed, compliance-first financial infrastructure, with a recent integration of a fiat anchor from a Stripe company enabling seamless transfers. The community is actively discussing its potential as an undervalued "asymmetric bet" set to become a foundational layer for global financial plumbing. This positioning, coupled with its proven throughput and regulatory readiness, makes it a compelling opportunity amidst the evolving crypto landscape.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as the community celebrates the FDA approval of YARTEMLEA, the first and only therapy for transplant-associated thrombotic microangiopathy in adults and children, sparking immense optimism among long-term investors. Many are eagerly discussing the potential for a significant re-rating of the company's valuation and a substantial short squeeze. This milestone, coupled with a multi-billion dollar partnership, has led to widespread belief that the company is now de-risked and poised for considerable growth.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is experiencing significant upward momentum, driven by recent regulatory relief, its ongoing strategic transformation, and strong Q3 earnings reported across the financial sector. This rally has propelled the stock to multi-year highs, sparking community debate about its sustainability amidst indicators of overbought conditions and discussions around notable corporate buybacks.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following the successful orbital launch of its BlueBird 6 satellite, a major milestone for direct-to-device 4G/5G connectivity from low Earth orbit. Despite the positive news, the stock experienced a "sell the news" dip, leading to community debate between short-term profit-takers and long-term investors who highlight future launches and the de-risking of ASTS's technology.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is trending as substantial insider buying, coupled with a public offering, conveys management's confidence despite a regulatory complete response letter for one of its lead programs. Community discussion is further energized by encouraging early clinical data for its experimental cancer treatment, BHV-1510, which demonstrated notable response rates and a favorable safety profile. Investors are now closely watching for upcoming readouts from its major depressive disorder and epilepsy programs for additional catalysts.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is a hot topic as its Anaphylm approval decision for anaphylaxis looms, with the PDUFA date nearing. Community sentiment is sharply divided between high confidence in a breakthrough needle-free oral film and concerns over previous regulatory setbacks and substantial short interest, as debate continues with competitor SPRY's nasal spray. Many are actively discussing Anaphylm's potential to redefine epinephrine delivery and its significant long-term value.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies is trending following a definitive agreement for acquisition by Sanofi for a notable cash value, which sent the stock surging. The community is actively discussing the offer, with many long-term shareholders expressing mixed sentiments: celebrating significant gains while a vocal segment believes the valuation is too low given the company's Hepatitis B vaccine, Heplisav-B, and promising shingles vaccine candidate.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following its recent FDA approval of Aqvesme, establishing it as the sole approved treatment for anemia in alpha- and beta-thalassemia. While the community is excited about this significant milestone, discussion is also focusing on the immediate stock dip, attributed to the mandated Risk Evaluation and Mitigation Strategy (REMS) program and a delayed commercial availability into early 2026.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending after promising preliminary Phase 3 data for its breast cancer immunotherapy showed an estimated 80% reduction in recurrence rates, driving intense bullish sentiment. The community is actively discussing perceived undervaluation, continued insider buying by the CEO, and the escalating potential for a significant short squeeze, fueled by exceptionally high borrow rates and a tightly held float.

Rain Enhancement Technologies Holdco, Inc. develops, manufactures, and commercializes ionization rainfall generation technology to provide additional rainfall for industries, supranational organizations, countries, and localities. The company is headquartered in Naples, FL.

Rain Enhancement Technologies Holdco Inc. - Ordinary Shares - Class A

Rain Enhancement Technologies (RAIN) is gaining significant attention amid strong community sentiment predicting a short squeeze due to an reportedly ultra-low float and high cost to borrow, with recent positive indications from its initial U.S. installations. Investors are actively discussing the company's innovative weather enhancement technology and its perceived undervaluation given substantial new contracts and a strengthened executive board, eagerly anticipating increased volume to fuel a potential rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TPI Composites (TPIC) stock fell 38% in premarket trading on Tuesday after the wind Turbine blade maker filed for bankruptcy to restructure its debt.The company stated that one of its lenders, Oaktree Capital Management, has agreed to provide support with $27.5 million in new capital, as well as $55 million from its existing loan agreement, to support its day-to-day operations. Oaktree has also allowed TPI to use cash collateral.“Despite recent progress, industry-wide pressures have created financial challenges that must be addressed. We explored a variety of alternatives to address the challenges facing the Company and believe that a Chapter 11 process is necessary to position the Company for success,” said Bill Siwek, Chief Executive Officer of TPI.Retail sentiment on Stocktwits was in the ‘extremely bullish’ territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:808/96;" src="https://news.stocktwits-cdn.com/TPIC_Aug_12_JPG_93ed7bdc19.webp" alt="TPIC-Aug 12.JPG" width="808" height="96"><figcaption>TPIC’s Sentiment Meter and Message Volume as of 05:14 a.m. ET on Aug. 12, 2025 | Source: Stocktwits</figcaption></figure>The company listed estimated assets between $500 million and $1 billion, with liabilities between $1 billion and $10 billion, Bloomberg News reported, citing a bankruptcy court filing dated Monday.The wind equipment maker’s bankruptcy filing hints toward a continued downward spiral for the once-booming industry in the U.S. Since taking office for the second time, U.S. President Donald Trump has severely criticized large wind projects, and his Republican allies in Congress have moved to slash incentives for new projects."Will be interesting to see how this goes short term… sounds like they were making progress but due to market conditions they are doing this voluntarily to come back stronger?" one user said.<stembedurl>https://stocktwits.com/notsurewhat/message/624704980</stembedurl>The company reported a net loss of $48.3 million for the first quarter, along with sales of $336.4 million. It has manufacturing facilities in the U.S., Spain, Turkey, and India, and customers include Vestas and GE.TPI stock has plunged nearly 85% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-coal-producer-hallador-energy-s-stock-is-soaring-premarket-today/chrDCOARd7j">Why Coal Producer Hallador Energy’s Stock Is Soaring Premarket Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Wind farm and solar panels seen from the air during a beautiful morning with mist and sun. Muntendam, Groningen, the Netherlands, September 2023.

TPI Composites Stock Sinks Premarket: What’s Behind The Slide?

The wind turbine blade maker has filed for bankruptcy, listing estimated assets of between $500 million and $1 billion, with liabilities ranging from $1 billion to $10 billion.

Equity

TPI Composites (TPIC) Reports Q2 Loss, Lags Revenue Estimates

TPI Composites (TPIC) delivered earnings and revenue surprises of -161.11% and -25.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

LegalZoom (LZ) Q2 Earnings Meet Estimates

LegalZoom (LZ) delivered earnings and revenue surprises of 0.00% and +5.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

TPI Composites (TPIC) Reports Q1 Loss, Tops Revenue Estimates

TPI Composites, Inc. is a holding company, which engages in the manufacturing of composite wind blades for the wind energy market. It operates through the following geographical segments: United States (US), Mexico, Europe, the Middle East and Africa (EMEA), and India. The US segment manufactures precision molding and assembly systems used for automotive business at Warren, Rhode Island facility. The Mexico segment includes the manufacturing of wind blades at three facilities in Juárez, Mexico, and two facilities in Matamoros, Mexico. The EMEA segment refers to the manufacturing of wind blades at two facilities in Izmir, Türkiye, and wind blade inspection and repair services in Türkiye. The India segment manufactures wind blades at manufacturing facility in Chennai, India. The company was founded by Everett Pearson and Neil Tillotson in 1968 and is headquartered in Scottsdale, AZ.

TPIC
TPI Composites Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TPIC News

TPICTPI Composites Inc